S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in
(Ad)
CNN calls 5G "the lifeblood of the new economy."

If you don't invest now, you'll regret it later.

NASDAQ:NXTM - NxStage Medical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$30.00
+30.00 (+∞)
(As of 02/21/2019)
Add
Compare
Today's Range
$29.98
Now: $30.00▼
$30.00
50-Day Range
$30.00
MA: $30.00▼
$30.00
52-Week Range
$23.17
Now: $30.00▼
$30.00
Volume2.61 million shs
Average Volume1.51 million shs
Market Capitalization$2.00 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.25
NxStage Medical, Inc, a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. Read More…

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:NXTM
Previous Symbol
CUSIP67072V10
CIK1333170
Webhttp://www.nxstage.com/
Phone978-687-4700

Debt

Debt-to-Equity RatioN/A
Current Ratio3.60
Quick Ratio2.69

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$393.94 million
Price / Sales5.08
Cash Flow$0.29 per share
Price / Cash Flow103.07
Book Value$3.22 per share
Price / Book9.32

Profitability

EPS (Most Recent Fiscal Year)($0.22)
Net Income$-14,470,000.00
Net Margins-1.29%
Return on Equity-2.50%
Return on Assets-1.60%

Miscellaneous

EmployeesN/A
Outstanding Shares66,680,000
Market Cap$2.00 billion
Next Earnings DateN/A
OptionableOptionable

Receive NXTM News and Ratings via Email

Sign-up to receive the latest news and ratings for NXTM and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


Each week, an exclusive group of investors receives access to a simple list of 3 stocks to put on their radar for the week ahead.

You can sign up today to receive access to next week's watchlist -- generated by a proprietary methodology -- at no cost or obligation.

NxStage Medical (NASDAQ:NXTM) Frequently Asked Questions

What is NxStage Medical's stock symbol?

NxStage Medical trades on the NASDAQ under the ticker symbol "NXTM."

How were NxStage Medical's earnings last quarter?

NxStage Medical, Inc. (NASDAQ:NXTM) issued its earnings results on Monday, August, 7th. The medical device company reported ($0.03) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.03) by $0.00. The medical device company had revenue of $92.20 million for the quarter, compared to analyst estimates of $96.47 million. NxStage Medical had a negative return on equity of 2.50% and a negative net margin of 1.29%. The company's revenue for the quarter was up .0% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.03) earnings per share. View NxStage Medical's Earnings History.

Has NxStage Medical been receiving favorable news coverage?

News coverage about NXTM stock has been trending extremely negative on Monday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. NxStage Medical earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave news coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for NxStage Medical.

Who are some of NxStage Medical's key competitors?

What other stocks do shareholders of NxStage Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NxStage Medical investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Och-Ziff Capital Management Group (OZM), Gran Tierra Energy (GTE) and ALJ Regional (ALJJ).

Who are NxStage Medical's key executives?

NxStage Medical's management team includes the folowing people:
  • Mr. Jeffrey H. Burbank, Founder, CEO & Director (Age 56)
  • Mr. Joseph E. Turk Jr., Pres (Age 51)
  • Mr. Matthew W. Towse, Sr. VP, CFO & Treasurer (Age 56)
  • Ms. Winifred L. Swan, Sr. VP, Gen. Counsel & Sec. (Age 55)
  • Dr. Allan J. Collins, Head of Scientific Advisory Board & Chief Medical Officer

What is NxStage Medical's stock price today?

One share of NXTM stock can currently be purchased for approximately $30.00.

How big of a company is NxStage Medical?

NxStage Medical has a market capitalization of $2.00 billion and generates $393.94 million in revenue each year. The medical device company earns $-14,470,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis. View Additional Information About NxStage Medical.

What is NxStage Medical's official website?

The official website for NxStage Medical is http://www.nxstage.com/.

How can I contact NxStage Medical?

NxStage Medical's mailing address is 350 MERRIMACK STREET, LAWRENCE MA, 01843. The medical device company can be reached via phone at 978-687-4700 or via email at [email protected]


MarketBeat Community Rating for NxStage Medical (NASDAQ NXTM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  366 (Vote Outperform)
Underperform Votes:  322 (Vote Underperform)
Total Votes:  688
MarketBeat's community ratings are surveys of what our community members think about NxStage Medical and other stocks. Vote "Outperform" if you believe NXTM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXTM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Featured Article: Roth IRA
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel